Novo Nordisk pitted a new weight-loss drug against Eli Lilly — and lost

1 week ago 32

Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as much weight as an Eli Lilly product.

Read Entire Article

Novo Nordisk pitted a new weight-loss drug against Eli Lilly — and lost

Related

Bitcoin Historically Bottoms Between These MVRV Levels—Where...

America’s crypto future in 2026: The signal investors are mi...

Pi Network’s PI Steals the Show With Big Rally, Bitcoin Stop...

Trending

Popular

CFTC expands payment stablecoin criteria to include national...

Strategy to initiate a bitcoin security program addressing q...

Broad-based bitcoin accumulation emerges after sharp capitul...

Cathie Wood’s ARK dumps $17M in Coinbase stock as shares fal...

More companies than usual are beating Wall Street’s expectat...

Over 23% of traders now expect interest rate cut at next FOM...

Crypto’s stress test hits balance sheets as Bitcoin, Ether c...

Galaxy Digital shares jump 18% after company approves $200 m...

Why normalization of digital asset treasuries is the next bi...

Tesla’s stock rallies to end a rough week